Lung cancer is the No. 1 cancer killer in the U.S. and the world, and small cell lung cancer is considered its most lethal form. Diagnosed with recurrent small cell lung cancer, Jim Gibson felt he was facing a certain death sentence when he sought treatment at Issels alternative cancer treatment centers in 2003. When standard cancer treatments did not work, Jim decided to try non-toxic integrative immunotherapy as a last resort. The decision saved his life. After just four weeks of exclusive Issels immunotherapy that included dendritic cell vaccine, Jim achieved complete tumor remission. Jim has now been cancer-free for 10 years and enjoys a healthy, active life. (Click to hear Jim’s story in his own words.)

As reported in the Sacramento Bee, “In recent years the surge of immunotherapy has given cancer sufferers new hope.” A leader in integrative immunotherapy for more than 60 years, Issels Integrative Oncology has been at the forefront of the immunotherapy movement that is now being embraced by practitioners of traditional medicine as “amazing” and “a game-changer” in the treatment of cancer. Many cancer researchers now believe that immunotherapy is the future of cancer treatment and our best hope for an eventual cure.

Immunotherapy enhances and harnesses the power of the body’s own immune system to target and destroy cancer cells. A non-toxic alternative cancer treatment, integrative immunotherapy does not batter the body with toxic chemotherapy or radiation so it does not produce the debilitating side effects that so many cancer patients fear. The non-toxic aspect and strong track record of immunotherapy is leading more cancer patients to consider it as a first choice for treatment rather than a last resort. As Issels patient Nicole Tupper says, “Try this first … it’s an amazing option.”